Shenzhen Xiaoxiongpipi Technology Co., Ltd. – Trademark Portfolio

Entity Type: 99

Shenzhen Xiaoxiongpipi Technology Co., Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include XXIONG. The owner is based in Shenzhen.

Xinniu Community,Minzhi St,Longhua Dist,

Rm. 370-2,Gangshen International Center,

Shenzhen 518100 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

XXIONG
XXIONG
Registered 2023

Trademark Classifications

Shenzhen Xiaoxiongpipi Technology Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Shenzhen Xiaoxiongpipi Technology Co., Ltd. have?

Shenzhen Xiaoxiongpipi Technology Co., Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Shenzhen Xiaoxiongpipi Technology Co., Ltd. file in?

Shenzhen Xiaoxiongpipi Technology Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are Shenzhen Xiaoxiongpipi Technology Co., Ltd.'s most well-known trademarks?

Shenzhen Xiaoxiongpipi Technology Co., Ltd.'s registered trademark portfolio includes well-known marks such as XXIONG. These are among 1 currently registered trademark in the portfolio.

What is Shenzhen Xiaoxiongpipi Technology Co., Ltd.'s trademark registration success rate?

Shenzhen Xiaoxiongpipi Technology Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.